Form D · Biotechnology
VAXINNATE CORP
Cranbury, NJ · CIK 0001174224
Offering snapshot reported Sep 28, 2015 · SEC filing
- Reported sold
- $3.25M Offering amount: $4.34M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 18, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 28, 2015 | Initial | $3,248,047 | No comparison | 14 | SEC filing |
| Oct 2, 2014 | Initial | $6,000,000 | No comparison | 9 | SEC filing |
| Feb 24, 2012 | Amendment | $24,810,408 | $8,130,656vs Feb 15, 2011 | 13 | SEC filing |
| Apr 8, 2011 | Amendment | $21,698,759 | $5,019,007vs Feb 15, 2011 | 12 | SEC filing |
| Feb 15, 2011 | Amendment | $16,679,752 | $11,471,960vs Mar 19, 2010 | 12 | SEC filing |
| Mar 19, 2010 | Initial | $5,207,792 | No comparison | 12 | SEC filing |
| May 19, 2009 | Initial | $15,000,000 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-248311
Source: Form D, filed Sep 28, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Seth F. Berkley | Director |
| Phillippe O. Chambon | Director |
| Philippe O. Chambon | Director |
| Andrew T. Drechsler | Executive |
| Julie Eskay Eagle | Director |
| Thomas Hofstaetter | Director, Executive, Promoter |
| Augustine Lawlor | Director |
| Kathleen A. Mc Gowan | Executive |
| Thomas Monath | Director |
| Wayne Pisano | Director, Executive |
| Seth Rudnick | Director |
| Timothy Shannon | Director |
| Alan R. Shaw | Director, Executive |
| Franklin H. Top, Jr. | Director |
| Lynda Tussey | Executive |
| Gregory Weinhoff | Director |
| David Williams | Director |
| Sam Wu | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3 Cedar Brook Drive
Cranbury, NJ, 08512
Cranbury, NJ, 08512